8 results
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Toxic Megacolon, Shock ... Epidemiology: • #1 ... post-ABx, but can ... be community-acquired ... 10 mg/kg IV x 1
Community Acquired Pneumonia (CAP) - Diagnosis and Management

Pneumonia Signs/Symptoms:
 • Confusion/disorientation (LR + 1.9)
 • Cough
Community Acquired ... Egophony (May appear 1- ... procalcitonin level Treatment ... Diagnosis #Management #treatment ... #Pulmonary #Community
Macrolides - Erythromycin, Clarithromycin, Azithromycin - Antibiotics Class Overview

50S Ribosomal Inhibitor (PO and IV)
Spectrum: Atypical organisms
exacerbations, community-acquired ... Ceftriaxone for CAP ... Used for MAC treatment ... patients with CD4 ... #Pharmacology #Antibiotics
Immune Reconstitution Inflammatory Syndrome - Overview of IRIS

What Is IRIS?
	• A state of hyperinflammatory response that
within the first 1 ... TB IRIS which can ... decrease in HIV-1 ... Leishmaniasis Differential ... Inflammatory #Syndrome #Differential
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
typically fall into 1 ... with presence of pulmonary ... essentially Cardiogenic Shock ... #diagnosis #differential ... icu #clinical #pharmacology
Diuretics and Agents Regulating Renal Excretion

Carbonic Anhydrase Inhibitors (Acetazolamide, Dichlorphenamide)
 • Glaucoma
 • Epilepsy
 • Altitude
Torsemide) • Acute pulmonary ... Inhibitors of Na+CI ... • Hypovolemic shock ... Tolvaptan) • Treatment ... Diuresis #Nephrology #Pharmacology
Nontuberculous Mycobacteria (NTM) Infections 

Mycobacterial species other than those belonging to the Mycobacterium tuberculosis complex and
and M. fortuitum can ... Complex (MAC): • Acquired ... patients such as: 1. ... Advanced HIV (CD4 ... NTM #Infections #differential
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
Epidemiology: • F > M: 9:1 ... Antinuclear antibodies ≥ 1: ... , INC risk PE, Pulmonary ... Adenocarcinoma Treatment ... lubricants • Pharmacologic